+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
H1N1 Vaccines Market by Product Type, Technology, End User, Distribution Channel, Dosage Form, Age Group - Global Forecast to 2030- Product Image
H1N1 Vaccines Market by Product Type, Technology, End User, Distribution Channel, Dosage Form, Age Group - Global Forecast to 2030- Product Image
Sale

H1N1 Vaccines Market by Product Type, Technology, End User, Distribution Channel, Dosage Form, Age Group - Global Forecast to 2030

  • PDF Icon

    Report

  • 180 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 4904545
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The H1N1 vaccines market is quickly evolving, marked by rapid technological advances and heightened public health collaboration. Industry executives must stay informed as new manufacturing methods, supply chain strategies, and regulatory dynamics are redefining competitive advantage for suppliers and buyers alike.

Market Snapshot: H1N1 Vaccines Market Growth and Outlook

The H1N1 vaccines market grew from USD 13.45 billion in 2024 to USD 18.42 billion in 2025, with expectations to reach USD 83.70 billion by 2030 at a CAGR of 35.61%. Robust investment in next-generation vaccine platforms, advancements in cell-based and recombinant production technologies, and strengthened global partnerships are driving sector momentum. Heightened focus from governments and public health authorities continues to support infrastructure, research, and supply chain enhancements—positioning the market for sustained expansion and resilience to future influenza outbreaks.

Scope & Segmentation of the H1N1 Vaccines Market

  • Product Types: Inactivated vaccines (including cell-based, egg-based, and recombinant), and live attenuated vaccines (primarily egg-based).
  • Technology: Cell-based, egg-based, and recombinant production techniques.
  • End Users: Clinics, hospitals, and public health centers.
  • Distribution Channels: Hospital, online, and retail pharmacies.
  • Dosage Forms: Multi-dose vials, pre-filled syringes.
  • Age Groups: Adults, children, seniors.
  • Geographical Coverage: Americas (United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (multiple countries), and Asia-Pacific (including China, India, Japan, Australia, Southeast Asia).
  • Industry Players Profiled: Sanofi Pasteur SA, GlaxoSmithKline plc, CSL Seqirus Pty Ltd, Novartis AG, Pfizer Inc., Takeda Pharmaceutical Company Limited, Moderna, Bharat Biotech, Bavarian Nordic A/S, Panacea Biotec Limited.

Key Takeaways for Decision-Makers

  • Broader adoption of cell-based and recombinant platforms is mitigating traditional supply chain limitations and reducing production cycle times for H1N1 vaccine manufacturers.
  • Strategic public-private partnerships and streamlined regulatory pathways now accelerate product development, regulatory review, and market launch, particularly in regions with robust health networks.
  • Segmentation by dosage form shows a growing industry preference for pre-filled syringes, offering both improved administration and operational efficiency; multi-dose vials remain key for large immunization programs.
  • Adult and senior populations contribute the highest demand volume, while pediatric uptake is steadily increasing as safety improvements are validated, shaping future product development and marketing priorities.
  • Digital health tools, including cold-chain monitoring and online engagement, are supporting efficient distribution and enhancing stakeholder confidence across the H1N1 immunization landscape.

Tariff Impact: 2025 US Regulatory Shifts in Focus

The introduction of new US tariffs on pharmaceutical raw materials and finished vaccines in 2025 significantly increased costs for facilities relying on international supplies, especially those using egg-based production. As a result, vaccine manufacturers are prioritizing domestic supplier relationships and adopting alternative production platforms with lower tariff exposure to improve operating margins. Public health programs and private buyers now face increased budget scrutiny and are driving more aggressive volume negotiations with suppliers. This shift is prompting a diversification of manufacturing locations and strengthening long-term security for supply chains across the market.

Methodology & Data Sources

This analysis synthesizes primary interviews with industry leaders, policymakers, and executives, combined with a rigorous review of peer-reviewed scientific literature, regulatory filings, and corporate disclosures. Findings are validated by triangulating multiple data sources, ensuring segmentation consistency and actionable market insights.

Why This Report Matters

  • Enables strategic planning by presenting a detailed breakdown of H1N1 vaccine types, technologies, and end-user segments.
  • Delivers targeted analysis of supply chain dynamics and regulatory environments across major global regions relevant to executive decision-making.
  • Empowers companies to benchmark operational and marketing approaches against leading manufacturers and adapt rapidly to evolving policy and market conditions.

Conclusion

The H1N1 vaccines market is characterized by dynamic change, technological innovation, and proactive regional strategies. Senior leaders can leverage these intelligence insights to strengthen market positioning and support resilient immunization programs into the future.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. H1N1 Vaccines Market, by Product Type
8.1. Introduction
8.2. Inactivated Vaccine
8.2.1. Cell Based
8.2.2. Egg Based
8.2.3. Recombinant
8.3. Live Attenuated Vaccine
8.3.1. Egg Based
9. H1N1 Vaccines Market, by Technology
9.1. Introduction
9.2. Cell Based
9.3. Egg Based
9.4. Recombinant
10. H1N1 Vaccines Market, by End User
10.1. Introduction
10.2. Clinics
10.3. Hospitals
10.4. Public Health Centers
11. H1N1 Vaccines Market, by Distribution Channel
11.1. Introduction
11.2. Hospital Pharmacies
11.3. Online Pharmacies
11.4. Retail Pharmacies
12. H1N1 Vaccines Market, by Dosage Form
12.1. Introduction
12.2. Multi-Dose Vials
12.3. Pre-Filled Syringes
13. H1N1 Vaccines Market, by Age Group
13.1. Introduction
13.2. Adults
13.3. Children
13.4. Seniors
14. Americas H1N1 Vaccines Market
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. Argentina
15. Europe, Middle East & Africa H1N1 Vaccines Market
15.1. Introduction
15.2. United Kingdom
15.3. Germany
15.4. France
15.5. Russia
15.6. Italy
15.7. Spain
15.8. United Arab Emirates
15.9. Saudi Arabia
15.10. South Africa
15.11. Denmark
15.12. Netherlands
15.13. Qatar
15.14. Finland
15.15. Sweden
15.16. Nigeria
15.17. Egypt
15.18. Turkey
15.19. Israel
15.20. Norway
15.21. Poland
15.22. Switzerland
16. Asia-Pacific H1N1 Vaccines Market
16.1. Introduction
16.2. China
16.3. India
16.4. Japan
16.5. Australia
16.6. South Korea
16.7. Indonesia
16.8. Thailand
16.9. Philippines
16.10. Malaysia
16.11. Singapore
16.12. Vietnam
16.13. Taiwan
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. Sanofi Pasteur SA
17.3.2. GlaxoSmithKline plc
17.3.3. CSL Seqirus Pty Ltd
17.3.4. Novartis AG
17.3.5. Pfizer Inc.
17.3.6. Takeda Pharmaceutical Company Limited
17.3.7. Moderna, Inc.
17.3.8. Bharat Biotech International Limited
17.3.9. Bavarian Nordic a/S
17.3.10. Panacea Biotec Limited
18. ResearchAI
19. ResearchStatistics
20. ResearchContacts
21. ResearchArticles
22. Appendix
List of Figures
FIGURE 1. H1N1 VACCINES MARKET MULTI-CURRENCY
FIGURE 2. H1N1 VACCINES MARKET MULTI-LANGUAGE
FIGURE 3. H1N1 VACCINES MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL H1N1 VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL H1N1 VACCINES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL H1N1 VACCINES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL H1N1 VACCINES MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL H1N1 VACCINES MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL H1N1 VACCINES MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 10. GLOBAL H1N1 VACCINES MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL H1N1 VACCINES MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL H1N1 VACCINES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL H1N1 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 14. GLOBAL H1N1 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL H1N1 VACCINES MARKET SIZE, BY DOSAGE FORM, 2024 VS 2030 (%)
FIGURE 16. GLOBAL H1N1 VACCINES MARKET SIZE, BY DOSAGE FORM, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL H1N1 VACCINES MARKET SIZE, BY AGE GROUP, 2024 VS 2030 (%)
FIGURE 18. GLOBAL H1N1 VACCINES MARKET SIZE, BY AGE GROUP, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. AMERICAS H1N1 VACCINES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. AMERICAS H1N1 VACCINES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. UNITED STATES H1N1 VACCINES MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 22. UNITED STATES H1N1 VACCINES MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA H1N1 VACCINES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA H1N1 VACCINES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. ASIA-PACIFIC H1N1 VACCINES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 26. ASIA-PACIFIC H1N1 VACCINES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. H1N1 VACCINES MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 28. H1N1 VACCINES MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. H1N1 VACCINES MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL H1N1 VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL H1N1 VACCINES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL H1N1 VACCINES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL H1N1 VACCINES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL H1N1 VACCINES MARKET SIZE, BY INACTIVATED VACCINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL H1N1 VACCINES MARKET SIZE, BY CELL BASED, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL H1N1 VACCINES MARKET SIZE, BY EGG BASED, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL H1N1 VACCINES MARKET SIZE, BY RECOMBINANT, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL H1N1 VACCINES MARKET SIZE, BY INACTIVATED VACCINE, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL H1N1 VACCINES MARKET SIZE, BY LIVE ATTENUATED VACCINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL H1N1 VACCINES MARKET SIZE, BY EGG BASED, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL H1N1 VACCINES MARKET SIZE, BY LIVE ATTENUATED VACCINE, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL H1N1 VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL H1N1 VACCINES MARKET SIZE, BY CELL BASED, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL H1N1 VACCINES MARKET SIZE, BY EGG BASED, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL H1N1 VACCINES MARKET SIZE, BY RECOMBINANT, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL H1N1 VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL H1N1 VACCINES MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL H1N1 VACCINES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL H1N1 VACCINES MARKET SIZE, BY PUBLIC HEALTH CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL H1N1 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL H1N1 VACCINES MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL H1N1 VACCINES MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL H1N1 VACCINES MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL H1N1 VACCINES MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL H1N1 VACCINES MARKET SIZE, BY MULTI-DOSE VIALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL H1N1 VACCINES MARKET SIZE, BY PRE-FILLED SYRINGES, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL H1N1 VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL H1N1 VACCINES MARKET SIZE, BY ADULTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL H1N1 VACCINES MARKET SIZE, BY CHILDREN, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL H1N1 VACCINES MARKET SIZE, BY SENIORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. AMERICAS H1N1 VACCINES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 35. AMERICAS H1N1 VACCINES MARKET SIZE, BY INACTIVATED VACCINE, 2018-2030 (USD MILLION)
TABLE 36. AMERICAS H1N1 VACCINES MARKET SIZE, BY LIVE ATTENUATED VACCINE, 2018-2030 (USD MILLION)
TABLE 37. AMERICAS H1N1 VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 38. AMERICAS H1N1 VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 39. AMERICAS H1N1 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 40. AMERICAS H1N1 VACCINES MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 41. AMERICAS H1N1 VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 42. AMERICAS H1N1 VACCINES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 43. UNITED STATES H1N1 VACCINES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 44. UNITED STATES H1N1 VACCINES MARKET SIZE, BY INACTIVATED VACCINE, 2018-2030 (USD MILLION)
TABLE 45. UNITED STATES H1N1 VACCINES MARKET SIZE, BY LIVE ATTENUATED VACCINE, 2018-2030 (USD MILLION)
TABLE 46. UNITED STATES H1N1 VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 47. UNITED STATES H1N1 VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 48. UNITED STATES H1N1 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 49. UNITED STATES H1N1 VACCINES MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 50. UNITED STATES H1N1 VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 51. UNITED STATES H1N1 VACCINES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 52. CANADA H1N1 VACCINES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 53. CANADA H1N1 VACCINES MARKET SIZE, BY INACTIVATED VACCINE, 2018-2030 (USD MILLION)
TABLE 54. CANADA H1N1 VACCINES MARKET SIZE, BY LIVE ATTENUATED VACCINE, 2018-2030 (USD MILLION)
TABLE 55. CANADA H1N1 VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 56. CANADA H1N1 VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 57. CANADA H1N1 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 58. CANADA H1N1 VACCINES MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 59. CANADA H1N1 VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 60. MEXICO H1N1 VACCINES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 61. MEXICO H1N1 VACCINES MARKET SIZE, BY INACTIVATED VACCINE, 2018-2030 (USD MILLION)
TABLE 62. MEXICO H1N1 VACCINES MARKET SIZE, BY LIVE ATTENUATED VACCINE, 2018-2030 (USD MILLION)
TABLE 63. MEXICO H1N1 VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 64. MEXICO H1N1 VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 65. MEXICO H1N1 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 66. MEXICO H1N1 VACCINES MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 67. MEXICO H1N1 VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 68. BRAZIL H1N1 VACCINES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 69. BRAZIL H1N1 VACCINES MARKET SIZE, BY INACTIVATED VACCINE, 2018-2030 (USD MILLION)
TABLE 70. BRAZIL H1N1 VACCINES MARKET SIZE, BY LIVE ATTENUATED VACCINE, 2018-2030 (USD MILLION)
TABLE 71. BRAZIL H1N1 VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 72. BRAZIL H1N1 VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 73. BRAZIL H1N1 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 74. BRAZIL H1N1 VACCINES MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 75. BRAZIL H1N1 VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 76. ARGENTINA H1N1 VACCINES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 77. ARGENTINA H1N1 VACCINES MARKET SIZE, BY INACTIVATED VACCINE, 2018-2030 (USD MILLION)
TABLE 78. ARGENTINA H1N1 VACCINES MARKET SIZE, BY LIVE ATTENUATED VACCINE, 2018-2030 (USD MILLION)
TABLE 79. ARGENTINA H1N1 VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 80. ARGENTINA H1N1 VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 81. ARGENTINA H1N1 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 82. ARGENTINA H1N1 VACCINES MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 83. ARGENTINA H1N1 VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 84. EUROPE, MIDDLE EAST & AFRICA H1N1 VACCINES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 85. EUROPE, MIDDLE EAST & AFRICA H1N1 VACCINES MARKET SIZE, BY INACTIVATED VACCINE, 2018-2030 (USD MILLION)
TABLE 86. EUROPE, MIDDLE EAST & AFRICA H1N1 VACCINES MARKET SIZE, BY LIVE ATTENUATED VACCINE, 2018-2030 (USD MILLION)
TABLE 87. EUROPE, MIDDLE EAST & AFRICA H1N1 VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 88. EUROPE, MIDDLE EAST & AFRICA H1N1 VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 89. EUROPE, MIDDLE EAST & AFRICA H1N1 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 90. EUROPE, MIDDLE EAST & AFRICA H1N1 VACCINES MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 91. EUROPE, MIDDLE EAST & AFRICA H1N1 VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 92. EUROPE, MIDDLE EAST & AFRICA H1N1 VACCINES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 93. UNITED KINGDOM H1N1 VACCINES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 94. UNITED KINGDOM H1N1 VACCINES MARKET SIZE, BY INACTIVATED VACCINE, 2018-2030 (USD MILLION)
TABLE 95. UNITED KINGDOM H1N1 VACCINES MARKET SIZE, BY LIVE ATTENUATED VACCINE, 2018-2030 (USD MILLION)
TABLE 96. UNITED KINGDOM H1N1 VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 97. UNITED KINGDOM H1N1 VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 98. UNITED KINGDOM H1N1 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 99. UNITED KINGDOM H1N1 VACCINES MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 100. UNITED KINGDOM H1N1 VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 101. GERMANY H1N1 VACCINES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 102. GERMANY H1N1 VACCINES MARKET SIZE, BY INACTIVATED VACCINE, 2018-2030 (USD MILLION)
TABLE 103. GERMANY H1N1 VACCINES MARKET SIZE, BY LIVE ATTENUATED VACCINE, 2018-2030 (USD MILLION)
TABLE 104. GERMANY H1N1 VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 105. GERMANY H1N1 VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 106. GERMANY H1N1 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 107. GERMANY H1N1 VACCINES MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 108. GERMANY H1N1 VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 109. FRANCE H1N1 VACCINES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 110. FRANCE H1N1 VACCINES MARKET SIZE, BY INACTIVATED VACCINE, 2018-2030 (USD MILLION)
TABLE 111. FRANCE H1N1 VACCINES MARKET SIZE, BY LIVE ATTENUATED VACCINE, 2018-2030 (USD MILLION)
TABLE 112. FRANCE H1N1 VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 113. FRANCE H1N1 VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 114. FRANCE H1N1 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 115. FRANCE H1N1 VACCINES MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 116. FRANCE H1N1 VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 117. RUSSIA H1N1 VACCINES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 118. RUSSIA H1N1 VACCINES MARKET SIZE, BY INACTIVATED VACCINE, 2018-2030 (USD MILLION)
TABLE 119. RUSSIA H1N1 VACCINES MARKET SIZE, BY LIVE ATTENUATED VACCINE, 2018-2030 (USD MILLION)
TABLE 120. RUSSIA H1N1 VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 121. RUSSIA H1N1 VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 122. RUSSIA H1N1 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 123. RUSSIA H1N1 VACCINES MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 124. RUSSIA H1N1 VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 125. ITALY H1N1 VACCINES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 126. ITALY H1N1 VACCINES MARKET SIZE, BY INACTIVATED VACCINE, 2018-2030 (USD MILLION)
TABLE 127. ITALY H1N1 VACCINES MARKET SIZE, BY LIVE ATTENUATED VACCINE, 2018-2030 (USD MILLION)
TABLE 128. ITALY H1N1 VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 129. ITALY H1N1 VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 130. ITALY H1N1 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 131. ITALY H1N1 VACCINES MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 132. ITALY H1N1 VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 133. SPAIN H1N1 VACCINES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 134. SPAIN H1N1 VACCINES MARKET SIZE, BY INACTIVATED VACCINE, 2018-2030 (USD MILLION)
TABLE 135. SPAIN H1N1 VACCINES MARKET SIZE, BY LIVE ATTENUATED VACCINE, 2018-2030 (USD MILLION)
TABLE 136. SPAIN H1N1 VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 137. SPAIN H1N1 VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 138. SPAIN H1N1 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 139. SPAIN H1N1 VACCINES MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 140. SPAIN H1N1 VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 141. UNITED ARAB EMIRATES H1N1 VACCINES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 142. UNITED ARAB EMIRATES H1N1 VACCINES MARKET SIZE, BY INACTIVATED VACCINE, 2018-2030 (USD MILLION)
TABLE 143. UNITED ARAB EMIRATES H1N1 VACCINES MARKET SIZE, BY LIVE ATTENUATED VACCINE, 2018-2030 (USD MILLION)
TABLE 144. UNITED ARAB EMIRATES H1N1 VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 145. UNITED ARAB EMIRATES H1N1 VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 146. UNITED ARAB EMIRATES H1N1 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 147. UNITED ARAB EMIRATES H1N1 VACCINES MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 148. UNITED ARAB EMIRATES H1N1 VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 149. SAUDI ARABIA H1N1 VACCINES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 150. SAUDI ARABIA H1N1 VACCINES MARKET SIZE, BY INACTIVATED VACCINE, 2018-2030 (USD MILLION)
TABLE 151. SAUDI ARABIA H1N1 VACCINES MARKET SIZE, BY LIVE ATTENUATED VACCINE, 2018-2030 (USD MILLION)
TABLE 152. SAUDI ARABIA H1N1 VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 153. SAUDI ARABIA H1N1 VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 154. SAUDI ARABIA H1N1 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 155. SAUDI ARABIA H1N1 VACCINES MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 156. SAUDI ARABIA H1N1 VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 157. SOUTH AFRICA H1N1 VACCINES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 158. SOUTH AFRICA H1N1 VACCINES MARKET SIZE, BY INACTIVATED VACCINE, 2018-2030 (USD MILLION)
TABLE 159. SOUTH AFRICA H1N1 VACCINES MARKET SIZE, BY LIVE ATTENUATED VACCINE, 2018-2030 (USD MILLION)
TABLE 160. SOUTH AFRICA H1N1 VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 161. SOUTH AFRICA H1N1 VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 162. SOUTH AFRICA H1N1 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 163. SOUTH AFRICA H1N1 VACCINES MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 164. SOUTH AFRICA H1N1 VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 165. DENMARK H1N1 VACCINES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 166. DENMARK H1N1 VACCINES MARKET SIZE, BY INACTIVATED VACCINE, 2018-2030 (USD MILLION)
TABLE 167. DENMARK H1N1 VACCINES MARKET SIZE, BY LIVE ATTENUATED VACCINE, 2018-2030 (USD MILLION)
TABLE 168. DENMARK H1N1 VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 169. DENMARK H1N1 VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 170. DENMARK H1N1 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 171. DENMARK H1N1 VACCINES MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 172. DENMARK H1N1 VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 173. NETHERLANDS H1N1 VACCINES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 174. NETHERLANDS H1N1 VACCINES MARKET SIZE, BY INACTIVATED VACCINE, 2018-2030 (USD MILLION)
TABLE 175. NETHERLANDS H1N1 VACCINES MARKET SIZE, BY LIVE ATTENUATED VACCINE, 2018-2030 (USD MILLION)
TABLE 176. NETHERLANDS H1N1 VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 177. NETHERLANDS H1N1 VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 178. NETHERLANDS H1N1 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 179. NETHERLANDS H1N1 VACCINES MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 180. NETHERLANDS H1N1 VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 181. QATAR H1N1 VACCINES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 182. QATAR H1N1 VACCINES MARKET SIZE, BY INACTIVATED VACCINE, 2018-2030 (USD MILLION)
TABLE 183. QATAR H1N1 VACCINES MARKET SIZE, BY LIVE ATTENUATED VACCINE, 2018-2030 (USD MILLION)
TABLE 184. QATAR H1N1 VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 185. QATAR H1N1 VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 186. QATAR H1N1 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 187. QATAR H1N1 VACCINES MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 188. QATAR H1N1 VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 189. FINLAND H1N1 VACCINES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 190. FINLAND H1N1 VACCINES MARKET SIZE, BY INACTIVATED VACCINE, 2018-2030 (USD MILLION)
TABLE 191. FINLAND H1N1 VACCINES MARKET SIZE, BY LIVE ATTENUATED VACCINE, 2018-2030 (USD MILLION)
TABLE 192. FINLAND H1N1 VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 193. FINLAND H1N1 VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 194. FINLAND H1N1 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 195. FINLAND H1N1 VACCINES MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 196. FINLAND H1N1 VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 197. SWEDEN H1N1 VACCINES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 198. SWEDEN H1N1 VACCINES MARKET SIZE, BY INACTIVATED VACCINE, 2018-2030 (USD MILLION)
TABLE 199. SWEDEN H1N1 VACCINES MARKET SIZE, BY LIVE ATTENUATED VACCINE, 2018-2030 (USD MILLION)
TABLE 200. SWEDEN H1N1 VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 201. SWEDEN H1N1 VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 202. SWEDEN H1N1 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 203. SWEDEN H1N1 VACCINES MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 204. SWEDEN H1N1 VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 205. NIGERIA H1N1 VACCINES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 206. NIGERIA H1N1 VACCINES MARKET SIZE, BY INACTIVATED VACCINE, 2018-2030 (USD MILLION)
TABLE 207. NIGERIA H1N1 VACCINES MARKET SIZE, BY LIVE ATTENUATED VACCINE, 2018-2030 (USD MILLION)
TABLE 208. NIGERIA H1N1 VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 209. NIGERIA H1N1 VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 210. NIGERIA H1N1 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 211. NIGERIA H1N1 VACCINES MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 212. NIGERIA H1N1 VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 213. EGYPT H1N1 VACCINES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 214. EGYPT H1N1 VACCINES MARKET SIZE, BY INACTIVATED VACCINE, 2018-2030 (USD MILLION)
TABLE 215. EGYPT H1N1 VACCINES MARKET SIZE, BY LIVE ATTENUATED VACCINE, 2018-2030 (USD MILLION)
TABLE 216. EGYPT H1N1 VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 217. EGYPT H1N1 VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 218. EGYPT H1N1 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 219. EGYPT H1N1 VACCINES MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 220. EGYPT H1N1 VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 221. TURKEY H1N1 VACCINES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 222. TURKEY H1N1 VACCINES MARKET SIZE, BY INACTIVATED VACCINE, 2018-2030 (USD MILLION)
TABLE 223. TURKEY H1N1 VACCINES MARKET SIZE, BY LIVE ATTENUATED VACCINE, 2018-2030 (USD MILLION)
TABLE 224. TURKEY H1N1 VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 225. TURKEY H1N1 VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 226. TURKEY H1N1 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 227. TURKEY H1N1 VACCINES MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 228. TURKEY H1N1 VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 229. ISRAEL H1N1 VACCINES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 230. ISRAEL H1N1 VACCINES MARKET SIZE, BY INACTIVATED VACCINE, 2018-2030 (USD MILLION)
TABLE 231. ISRAEL H1N1 VACCINES MARKET SIZE, BY LIVE ATTENUATED VACCINE, 2018-2030 (USD MILLION)
TABLE 232. ISRAEL H1N1 VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 233. ISRAEL H1N1 VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 234. ISRAEL H1N1 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 235. ISRAEL H1N1 VACCINES MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 236. ISRAEL H1N1 VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 237. NORWAY H1N1 VACCINES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 238. NORWAY H1N1 VACCINES MARKET SIZE, BY INACTIVATED VACCINE, 2018-2030 (USD MILLION)
TABLE 239. NORWAY H1N1 VACCINES MARKET SIZE, BY LIVE ATTENUATED VACCINE, 2018-2030 (USD MILLION)
TABLE 240. NORWAY H1N1 VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 241. NORWAY H1N1 VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 242. NORWAY H1N1 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 243. NORWAY H1N1 VACCINES MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 244. NORWAY H1N1 VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 245. POLAND H1N1 VACCINES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 246. POLAND H1N1 VACCINES MARKET SIZE, BY INACTIVATED VACCINE, 2018-2030 (USD MILLION)
TABLE 247. POLAND H1N1 VACCINES MARKET SIZE, BY LIVE ATTENUATED VACCINE, 2018-2030 (USD MILLION)
TABLE 248. POLAND H1N1 VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 249. POLAND H1N1 VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 250. POLAND H1N1 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 251. POLAND H1N1 VACCINES MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 252. POLAND H1N1 VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 253. SWITZERLAND H1N1 VACCINES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 254. SWITZERLAND H1N1 VACCINES MARKET SIZE, BY INACTIVATED VACCINE, 2018-2030 (USD MILLION)
TABLE 255. SWITZERLAND H1N1 VACCINES MARKET SIZE, BY LIVE ATTENUATED VACCINE, 2018-2030 (USD MILLION)
TABLE 256. SWITZERLAND H1N1 VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 257. SWITZERLAND H1N1 VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 258. SWITZERLAND H1N1 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 259. SWITZERLAND H1N1 VACCINES MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 260. SWITZERLAND H1N1 VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 261. ASIA-PACIFIC H1N1 VACCINES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 262. ASIA-PACIFIC H1N1 VACCINES MARKET SIZE, BY INACTIVATED VACCINE, 2018-2030 (USD MILLION)
TABLE 263. ASIA-PACIFIC H1N1 VACCINES MARKET SIZE, BY LIVE ATTENUATED VACCINE, 2018-2030 (USD MILLION)
TABLE 264. ASIA-PACIFIC H1N1 VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 265. ASIA-PACIFIC H1N1 VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 266. ASIA-PACIFIC H1N1 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 267. ASIA-PACIFIC H1N1 VACCINES MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 268. ASIA-PACIFIC H1N1 VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 269. ASIA-PACIFIC H1N1 VACCINES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 270. CHINA H1N1 VACCINES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 271. CHINA H1N1 VACCINES MARKET SIZE, BY INACTIVATED VACCINE, 2018-2030 (USD MILLION)
TABLE 272. CHINA H1N1 VACCINES MARKET SIZE, BY LIVE ATTENUATED VACCINE, 2018-2030 (USD MILLION)
TABLE 273. CHINA H1N1 VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 274. CHINA H1N1 VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 275. CHINA H1N1 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 276. CHINA H1N1 VACCINES MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 277. CHINA H1N1 VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 278. INDIA H1N1 VACCINES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 279. INDIA H1N1 VACCINES MARKET SIZE, BY INACTIVATED VACCINE, 2018-2030 (USD MILLION)
TABLE 280. INDIA H1N1 VACCINES MARKET SIZE, BY LIVE ATTENUATED VACCINE, 2018-2030 (USD MILLION)
TABLE 281. INDIA H1N1 VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 282. INDIA H1N1 VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 283. INDIA H1N1 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 284. INDIA H1N1 VACCINES MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 285. INDIA H1N1 VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 286. JAPAN H1N1 VACCINES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 287. JAPAN H1N1 VACCINES MARKET SIZE, BY INACTIVATED VACCINE, 2018-2030 (USD MILLION)
TABLE 288. JAPAN H1N1 VACCINES MARKET SIZE, BY LIVE ATTENUATED VACCINE, 2018-2030 (USD MILLION)
TABLE 289. JAPAN H1N1 VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 290. JAPAN H1N1 VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 291. JAPAN H1N1 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 292. JAPAN H1N1 VACCINES MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 293. JAPAN H1N1 VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 294. AUSTRALIA H1N1 VACCINES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 295. AUSTRALIA H1N1 VACCINES MARKET SIZE, BY INACTIVATED VACCINE, 2018-2030 (USD MILLION)
TABLE 296. AUSTRALIA H1N1 VACCINES MARKET SIZE, BY LIVE ATTENUATED VACCINE, 2018-2030 (USD MILLION)
TABLE 297. AUSTRALIA H1N1 VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 298. AUSTRALIA H1N1 VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 299. AUSTRALIA H1N1 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 300. AUSTRALIA H1N1 VACCINES MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 301. AUSTRALIA H1N1 VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 302. SOUTH KOREA H1N1 VACCINES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 303. SOUTH KOREA H1N1 VACCINES MARKET SIZE, BY INACTIVATED VACCINE, 2018-2030 (USD MILLION)
TABLE 304. SOUTH KOREA H1N1 VACCINES MARKET SIZE, BY LIVE ATTENUATED VACCINE, 2018-2030 (USD MILLION)
TABLE 305. SOUTH KOREA H1N1 VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 306. SOUTH KOREA H1N1 VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 307. SOUTH KOREA H1N1 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 308. SOUTH KOREA H1N1 VACCINES MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 309. SOUTH KOREA H1N1 VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 310. INDONESIA H1N1 VACCINES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 311. INDONESIA H1N1 VACCINES MARKET SIZE, BY INACTIVATED VACCINE, 2018-2030 (USD MILLION)
TABLE 312. INDONESIA H1N1 VACCINES MARKET SIZE, BY LIVE ATTENUATED VACCINE, 2018-2030 (USD MILLION)
TABLE 313. INDONESIA H1N1 VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 314. INDONESIA H1N1 VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 315. INDONESIA H1N1 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 316. INDONESIA H1N1 VACCINES MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 317. INDONESIA H1N1 VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 318. THAILAND H1N1 VACCINES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 319. THAILAND H1N1 VACCINES MARKET SIZE, BY INACTIVATED VACCINE, 2018-2030 (USD MILLION)
TABLE 320. THAILAND H1N1 VACCINES MARKET SIZE, BY LIVE ATTENUATED VACCINE, 2018-2030 (USD MILLION)
TABLE 321. THAILAND H1N1 VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 322. THAILAND H1N1 VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 323. THAILAND H1N1 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 324. THAILAND H1N1 VACCINES MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 325. THAILAND H1N1 VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 326. PHILIPPINES H1N1 VACCINES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 327. PHILIPPINES H1N1 VACCINES MARKET SIZE, BY INACTIVATED VACCINE, 2018-2030 (USD MILLION)
TABLE 328. PHILIPPINES H1N1 VACCINES MARKET SIZE, BY LIVE ATTENUATED VACCINE, 2018-2030 (USD MILLION)
TABLE 329. PHILIPPINES H1N1 VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 330. PHILIPPINES H1N1 VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 331. PHILIPPINES H1N1 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 332. PHILIPPINES H1N1 VACCINES MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 333. PHILIPPINES H1N1 VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 334. MALAYSIA H1N1 VACCINES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 335. MALAYSIA H1N1 VACCINES MARKET SIZE, BY INACTIVATED VACCINE, 2018-2030 (USD MILLION)
TABLE 336. MALAYSIA H1N1 VACCINES MARKET SIZE, BY LIVE ATTENUATED VACCINE, 2018-2030 (USD MILLION)
TABLE 337. MALAYSIA H1N1 VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 338. MALAYSIA H1N1 VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 339. MALAYSIA H1N1 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 340. MALAYSIA H1N1 VACCINES MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 341. MALAYSIA H1N1 VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 342. SINGAPORE H1N1 VACCINES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 343. SINGAPORE H1N1 VACCINES MARKET SIZE, BY INACTIVATED VACCINE, 2018-2030 (USD MILLION)
TABLE 344. SINGAPORE H1N1 VACCINES MARKET SIZE, BY LIVE ATTENUATED VACCINE, 2018-2030 (USD MILLION)
TABLE 345. SINGAPORE H1N1 VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 346. SINGAPORE H1N1 VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 347. SINGAPORE H1N1 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 348. SINGAPORE H1N1 VACCINES MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 349. SINGAPORE H1N1 VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 350. VIETNAM H1N1 VACCINES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 351. VIETNAM H1N1 VACCINES MARKET SIZE, BY INACTIVATED VACCINE, 2018-2030 (USD MILLION)
TABLE 352. VIETNAM H1N1 VACCINES MARKET SIZE, BY LIVE ATTENUATED VACCINE, 2018-2030 (USD MILLION)
TABLE 353. VIETNAM H1N1 VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 354. VIETNAM H1N1 VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 355. VIETNAM H1N1 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 356. VIETNAM H1N1 VACCINES MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 357. VIETNAM H1N1 VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 358. TAIWAN H1N1 VACCINES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 359. TAIWAN H1N1 VACCINES MARKET SIZE, BY INACTIVATED VACCINE, 2018-2030 (USD MILLION)
TABLE 360. TAIWAN H1N1 VACCINES MARKET SIZE, BY LIVE ATTENUATED VACCINE, 2018-2030 (USD MILLION)
TABLE 361. TAIWAN H1N1 VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 362. TAIWAN H1N1 VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 363. TAIWAN H1N1 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this H1N1 Vaccines market report include:
  • Sanofi Pasteur SA
  • GlaxoSmithKline plc
  • CSL Seqirus Pty Ltd
  • Novartis AG
  • Pfizer Inc.
  • Takeda Pharmaceutical Company Limited
  • Moderna, Inc.
  • Bharat Biotech International Limited
  • Bavarian Nordic A/S
  • Panacea Biotec Limited

Table Information

Report AttributeDetails
No. of Pages180
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 18.42 Billion
Forecasted Market Value ( USD ) by 2030 $ 83.7 Billion
Compound Annual Growth Rate35.6%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

H1N1 Vaccines - Global Strategic Business Report - Product Image

H1N1 Vaccines - Global Strategic Business Report

  • Report
  • 268 Pages
  • Global
From
H1N1 Vaccine Market Report 2025 - Product Image

H1N1 Vaccine Market Report 2025

  • Report
  • 200 Pages
  • Global
From
H1N1 Vaccines Market Report by Vaccine Type (Intramuscular, Intranasal, Intradermal), Market Type (Public, Private), and Region 2025-2033 - Product Image

H1N1 Vaccines Market Report by Vaccine Type (Intramuscular, Intranasal, Intradermal), Market Type (Public, Private), and Region 2025-2033

  • Report
  • 143 Pages
  • Global
From
H1N1 Vaccines Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

H1N1 Vaccines Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 186 Pages
  • Global
From
India Influenza Vaccine Market, Region, Competition, Forecast & Opportunities, 2020-2030F - Product Image

India Influenza Vaccine Market, Region, Competition, Forecast & Opportunities, 2020-2030F

  • Report
  • 85 Pages
  • India
From

About the H1N1 Vaccine Market

The H1N1 Vaccine is a vaccine developed to protect against the H1N1 strain of influenza, also known as swine flu. It is a type of inactivated vaccine, meaning it contains killed virus particles that are unable to cause infection. The vaccine is administered through injection and is recommended for people of all ages. It is especially important for those at high risk of complications from the virus, such as pregnant women, young children, and people with weakened immune systems. The H1N1 Vaccine market is a subset of the larger Vaccines market, which includes a wide range of products designed to protect against infectious diseases. Vaccines are an important tool in public health, as they can help reduce the spread of disease and protect vulnerable populations. Some companies in the H1N1 Vaccine market include Sanofi Pasteur, GlaxoSmithKline, Merck, and Pfizer. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.